{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:49:28Z","timestamp":1792954168413,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03315-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:33:18Z","timestamp":1782718398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the link between genomic instability and tumor immune evasion in oral squamous cell carcinoma: Role of CBMN assay and emerging perspectives"],"prefix":"10.1007","volume":"43","author":[{"given":"Asad","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbeena","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"2","key":"3315_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/medsci11020042","volume":"11","author":"A Barsouk","year":"2023","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci. 2023;11(2):42.","journal-title":"Med Sci"},{"issue":"Issue 9","key":"3315_CR2","first-page":"108","volume":"5","author":"K Arif","year":"2021","unstructured":"Arif K, Shaikh F, Khan R, Arif S, Arif H. CURRENT ASPECTS OF ORAL SQUAMOUS CELL CARCINOMA IN PAKISTAN: A REVIEW. Int J Med Biomedical Stud. 2021;5(Issue 9):108\u201313.","journal-title":"Int J Med Biomedical Stud"},{"key":"3315_CR3","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K, Mandoli A. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451.","journal-title":"Oral Oncol"},{"issue":"9","key":"3315_CR4","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3390\/jcm12093264","volume":"12","author":"L Nokovitch","year":"2023","unstructured":"Nokovitch L, Maquet C, Crampon F, Taihi I, Roussel L-M, Obongo R, Virard F, Fervers B, Deneuve S. Oral cavity squamous cell carcinoma risk factors: state of the art. J Clin Med. 2023;12(9):3264.","journal-title":"J Clin Med"},{"issue":"1","key":"3315_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"key":"3315_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.ircmb.2021.05.004","volume":"364","author":"H Li","year":"2021","unstructured":"Li H, Zimmerman SE, Weyemi U. Genomic instability and metabolism in cancer. Int Rev Cell Mol Biology. 2021;364:241\u201365.","journal-title":"Int Rev Cell Mol Biology"},{"issue":"3","key":"3315_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.oraloncology.2003.08.019","volume":"40","author":"S Zienolddiny","year":"2004","unstructured":"Zienolddiny S, Aguelon A-M, Mironov N, Mathew B, Thomas G, Sankaranarayanan R, Yamasaki H. Genomic instability in oral squamous cell carcinoma: relationship to betel-quid chewing. Oral Oncol. 2004;40(3):298\u2013303.","journal-title":"Oral Oncol"},{"issue":"8","key":"3315_CR8","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.3390\/curroncol29080437","volume":"29","author":"SG Doukas","year":"2022","unstructured":"Doukas SG, Vageli DP, Doukas PG, Nikitovic D, Tsatsakis A, Judson BL. The effect of tobacco smoke N-Nitrosamines, NNK and NDEA, and nicotine, on DNA mismatch repair mechanism and miRNA markers, in hypopharyngeal squamous cell carcinoma: an in vivo model and clinical evidence. Curr Oncol. 2022;29(8):5531\u201349.","journal-title":"Curr Oncol"},{"key":"3315_CR9","doi-asserted-by":"publisher","first-page":"e2017009","DOI":"10.4178\/epih.e2017009","volume":"39","author":"K Niaz","year":"2017","unstructured":"Niaz K, Maqbool F, Khan F, Bahadar H, Hassan FI, Abdollahi M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol health. 2017;39:e2017009.","journal-title":"Epidemiol health"},{"issue":"5","key":"3315_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/carcin\/bgae018","volume":"45","author":"LA Peterson","year":"2024","unstructured":"Peterson LA, Stanfill SB, Hecht SS. An update on the formation in tobacco, toxicity and carcinogenicity of N \u02b9-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 2024;45(5):275\u201387.","journal-title":"Carcinogenesis"},{"issue":"9","key":"3315_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/10826084.2019.1657149","volume":"55","author":"S Gunjal","year":"2020","unstructured":"Gunjal S, Pateel DGS, Yang Y-H, Doss JG, Bilal S, Maling TH, Mehrotra R, Cheong SC, Zain RBM. An overview on betel quid and areca nut practice and control in selected Asian and South East Asian countries. Subst Use Misuse. 2020;55(9):1533\u201344.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"3315_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1574892810666150317144817","volume":"10","author":"N Shah","year":"2015","unstructured":"Shah N, Manjunatha SS, Shah BS, Dagrus V, Soni K, Shah N S. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study. Recent Pat Anti-cancer Drug Discov. 2015;10(2):233\u20138.","journal-title":"Recent Pat Anti-cancer Drug Discov"},{"issue":"2","key":"3315_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/jomfp.JOMFP_221_19","volume":"23","author":"PK Singam","year":"2019","unstructured":"Singam PK, Majumdar S, Uppala D, Kotina S, Namana M, Ayyagari KR. Evaluation of genotoxicity by micronucleus assay in oral leukoplakia and oral squamous cell carcinoma with deleterious habits. J Oral Maxillofacial Pathol. 2019;23(2):300.","journal-title":"J Oral Maxillofacial Pathol"},{"issue":"1","key":"3315_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2225\/vol3-issue1-fulltext-5","volume":"3","author":"N-H Park","year":"2000","unstructured":"Park N-H, Kang MK. Genetic instability and oral cancer. Electron J Biotechnol. 2000;3(1):31\u201365.","journal-title":"Electron J Biotechnol"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"1462496","DOI":"10.3389\/fimmu.2024.1462496","volume":"15","author":"M Requesens","year":"2024","unstructured":"Requesens M, Foijer F, Nijman HW, De Bruyn M. Genomic instability as a driver and suppressor of anti-tumor immunity. Front Immunol. 2024;15:1462496.","journal-title":"Front Immunol"},{"issue":"12","key":"3315_CR16","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS\u2013STING pathway and cancer. Nat cancer. 2022;3(12):1452\u201363.","journal-title":"Nat cancer"},{"issue":"1","key":"3315_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12672-025-01997-3","volume":"16","author":"L He","year":"2025","unstructured":"He L, Wan M, Yang X, Meng H. Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment. Discover Oncol. 2025;16(1):257.","journal-title":"Discover Oncol"},{"key":"3315_CR18","doi-asserted-by":"crossref","unstructured":"Ooyama T, Hirayama M, Seki Y, Iwamoto A, Yoshida R, Nakayama H. Pretreatment nutritional indices are associated with survival and T-cell exhaustion in recurrent or metastatic oral squamous cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective cohort study. International Journal of Oral and Maxillofacial Surgery; 2025.","DOI":"10.1016\/j.ijom.2025.01.010"},{"issue":"2","key":"3315_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/jcm14020606","volume":"14","author":"S Sutera","year":"2025","unstructured":"Sutera S, Furch\u00ec OA, Pentenero M. Investigating Tumor-Infiltrating Lymphocytes in the Microenvironment of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMDs): Can They Shift Our Perspective? A Scoping Review. J Clin Med. 2025;14(2):606.","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"3315_CR20","first-page":"81","volume":"455","author":"M Fenech","year":"2000","unstructured":"Fenech M. The in vitro micronucleus technique. Mutat Research\/Fundamental Mol Mech Mutagen. 2000;455(1\u20132):81\u201395.","journal-title":"Mutat Research\/Fundamental Mol Mech Mutagen"},{"issue":"5","key":"3315_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nprot.2007.77","volume":"2","author":"M Fenech","year":"2007","unstructured":"Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2007;2(5):1084\u2013104.","journal-title":"Nat Protoc"},{"issue":"12","key":"3315_CR22","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1158\/0008-5472.CAN-06-0326","volume":"66","author":"RA El-Zein","year":"2006","unstructured":"El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006;66(12):6449\u201356.","journal-title":"Cancer Res"},{"key":"3315_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fonc.2019.01054","volume":"9","author":"G-z Huang","year":"2019","unstructured":"Huang G-z, Wu Q-q, Zheng Z-n, Shao T-r, Lv X-Z. Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma. Front Oncol. 2019;9:1054.","journal-title":"Front Oncol"},{"issue":"6","key":"3315_CR24","first-page":"307","volume":"2","author":"SJ Alrawi","year":"2005","unstructured":"Alrawi SJ, Stoler D, Tan D, Dayton M, Loree T, Gibbs JF, Rigual N, Sait S, Khoury T, Hicks W. Genomic instability, DNA alterations and tumor eosinophilic expression in head and neck squamous cell carcinoma. Cancer Genomics Proteomics. 2005;2(6):307\u201316.","journal-title":"Cancer Genomics Proteomics"},{"issue":"5","key":"3315_CR25","first-page":"3579","volume":"18","author":"Q Wu","year":"2019","unstructured":"Wu Q, Cao R, Chen J, Xie X. Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma. Experimental Therapeutic Med. 2019;18(5):3579\u201387.","journal-title":"Experimental Therapeutic Med"},{"issue":"6","key":"3315_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.pathol.2018.06.002","volume":"50","author":"H Shimomura","year":"2018","unstructured":"Shimomura H, Sasahira T, Nakashima C, Shimomura-Kurihara M, Kirita T. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma. Pathology. 2018;50(6):642\u20137.","journal-title":"Pathology"},{"key":"3315_CR27","volume-title":"Pakistan: GLOBOCAN 2022 Fact Sheet","author":"J Ferlay","year":"2022","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Pakistan: GLOBOCAN 2022 Fact Sheet. In. Lyon, France: International Agency for Research on Cancer; 2022."},{"issue":"1","key":"3315_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, Nice EC, Tang J, Huang C. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44.","journal-title":"Int J Oral Sci"},{"key":"3315_CR29","doi-asserted-by":"crossref","unstructured":"Fatima J, Fatima E, Mehmood F, Ishtiaq I, Khan MA, Khurshid HMS, Kashif M, Shahzad HM. 2024. Comprehensive analysis of oral squamous cell carcinomas: clinicpidemiological, and histopathological insights with a focus on prognostic factors and survival time. Cureus 16(2).","DOI":"10.7759\/cureus.54394"},{"issue":"1","key":"3315_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.52206\/jsmc.2025.15.1.897","volume":"15","author":"A Shah","year":"2025","unstructured":"Shah A, Uddin Z, Masooma S, Akhtar R, Kumar T. Pattern and Site Distribution of Oral Squamous Cell Carcinoma. J Saidu Med Coll. 2025;15(1):44\u20139.","journal-title":"J Saidu Med Coll"},{"issue":"4","key":"3315_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bulcan.2019.12.011","volume":"107","author":"G Abbas","year":"2020","unstructured":"Abbas G, Shah S, Hanif M, Asghar A, Shafique M, Ashraf K. Cancer prevalence, incidence and mortality rates in Pakistan in 2018. Bull Cancer. 2020;107(4):517\u20138.","journal-title":"Bull Cancer"},{"issue":"2","key":"3315_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/dj12020025","volume":"12","author":"MF Khan","year":"2024","unstructured":"Khan MF, Hayhoe RP, Kabir R. Exploring the risk factors for oral Cancer in Pakistan: a systematic literature review. Dentistry J. 2024;12(2):25.","journal-title":"Dentistry J"},{"key":"3315_CR33","doi-asserted-by":"crossref","unstructured":"Savitha S, Mohan MR, Prabu D, Dhamodhar D, Sindhu R, Nimmy P. 2024. Prevalence of Oral Cancer in India: A Systematic Review. Indian J Public Health Res Dev 15(4).","DOI":"10.37506\/1yqne619"},{"issue":"1","key":"3315_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12903-024-04717-5","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xie W, Ye H, Zhu J, Sun G, Zhang Y, Sheng C, Li J, Liu H, Zheng Z. Mortality and disease burden of oral cancer in China: a time-trend analysis on the China Death Surveillance Database from 2006 to 2021. BMC Oral Health. 2024;24(1):938.","journal-title":"BMC Oral Health"},{"issue":"8","key":"3315_CR35","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1111\/odi.14906","volume":"30","author":"AM Filho","year":"2024","unstructured":"Filho AM, Warnakulasuriya S. Epidemiology of oral cancer in South and South-East Asia: Incidence and mortality. Oral Dis. 2024;30(8):4847\u201354.","journal-title":"Oral Dis"},{"issue":"14","key":"3315_CR36","doi-asserted-by":"publisher","first-page":"e93652","DOI":"10.1172\/jci.insight.93652","volume":"2","author":"Z Feng","year":"2017","unstructured":"Feng Z, Bethmann D, Kappler M, Ballesteros-Merino C, Eckert A, Bell RB, Cheng A, Bui T, Leidner R, Urba WJ. Multiparametric immune profiling in HPV\u2013oral squamous cell cancer. JCI insight. 2017;2(14):e93652.","journal-title":"JCI insight"},{"key":"3315_CR37","doi-asserted-by":"crossref","unstructured":"Roza ALOC, Kowalski LP, William WN Jr, de Castro G Jr, Chaves ALF, Ara\u00fajo ALD, Ribeiro ACP, Brandao TB, Lopes MA, Vargas PA. 2021. Oral leukoplakia and erythroplakia in young patients: a systematic review. Oral surgery, oral medicine, oral pathology and oral radiology. 131(1): 73\u201384.","DOI":"10.1016\/j.oooo.2020.09.002"},{"key":"3315_CR38","doi-asserted-by":"publisher","first-page":"106699","DOI":"10.1016\/j.oraloncology.2024.106699","volume":"150","author":"NCM Santana","year":"2024","unstructured":"Santana NCM, de Sena ACVP, da Silva Rocha PA, de Arruda JAA, Torres-Pereira CC, Abreu LG, Fournier BP, Warnakulasuriya S, Silva TA. Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia\u2013A systematic review. Oral Oncol. 2024;150:106699.","journal-title":"Oral Oncol"},{"issue":"3","key":"3315_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2014an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3315_CR40","doi-asserted-by":"crossref","unstructured":"Shen Z. Genomic instability and cancer: an introduction. In: Oxford University Press; 2011. pp. 1\u20133.","DOI":"10.1093\/jmcb\/mjq057"},{"issue":"1","key":"3315_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-genet-111212-133232","volume":"47","author":"A Aguilera","year":"2013","unstructured":"Aguilera A, Garc\u00eda-Muse T. Causes of genome instability. Annu Rev Genet. 2013;47(1):1\u201332.","journal-title":"Annu Rev Genet"},{"issue":"2","key":"3315_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tig.2007.11.006","volume":"24","author":"JB Geigl","year":"2008","unstructured":"Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR. Defining \u2018chromosomal instability\u2019. Trends Genet. 2008;24(2):64\u20139.","journal-title":"Trends Genet"},{"issue":"6","key":"3315_CR43","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1016\/j.cub.2010.01.034","volume":"20","author":"SL Thompson","year":"2010","unstructured":"Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20(6):R285\u201395.","journal-title":"Curr Biol"},{"issue":"7976","key":"3315_CR44","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, Lettera E, Deyell M, Tavora B, Havel JJ. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620(7976):1080\u20138.","journal-title":"Nature"},{"key":"3315_CR45","doi-asserted-by":"publisher","first-page":"1067735","DOI":"10.3389\/fonc.2023.1067735","volume":"13","author":"Y-Y Liao","year":"2023","unstructured":"Liao Y-Y, Cao W-M. The progress in our understanding of CIN in breast cancer research. Front Oncol. 2023;13:1067735.","journal-title":"Front Oncol"},{"issue":"1","key":"3315_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","volume":"13","author":"A Elmusrati","year":"2021","unstructured":"Elmusrati A, Wang J, Wang C-Y. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int J Oral Sci. 2021;13(1):24.","journal-title":"Int J Oral Sci"},{"issue":"2","key":"3315_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.radonc.2016.02.009","volume":"118","author":"A Hong","year":"2016","unstructured":"Hong A, Zhang X, Jones D, Veillard A-S, Zhang M, Martin A, Lyons JG, Lee CS, Rose B. Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma. Radiother Oncol. 2016;118(2):342\u20139.","journal-title":"Radiother Oncol"},{"issue":"6","key":"3315_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/0022034518759068","volume":"97","author":"A Lindemann","year":"2018","unstructured":"Lindemann A, Takahashi H, Patel A, Osman A, Myers J. Targeting the DNA damage response in OSCC with TP 53 mutations. J Dent Res. 2018;97(6):635\u201344.","journal-title":"J Dent Res"},{"issue":"6","key":"3315_CR49","first-page":"1569","volume":"23","author":"V Ragos","year":"2018","unstructured":"Ragos V, Mastronikolis NS, Tsiambas E, Baliou E, Mastronikolis SN, Tsoukalas N, Patsouri EE, Fotiades PP. p53 mutations in oral cavity carcinoma. J BUON. 2018;23(6):1569\u201372.","journal-title":"J BUON"},{"issue":"7","key":"3315_CR50","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1158\/1078-0432.CCR-17-0721","volume":"24","author":"VC Sandulache","year":"2018","unstructured":"Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S. High-risk TP53 mutations are associated with extranodal extension in oral cavity squamous cell carcinoma. Clin Cancer Res. 2018;24(7):1727\u201333.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3315_CR51","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-16-1553","volume":"77","author":"N Andor","year":"2017","unstructured":"Andor N, Maley CC, Ji HP. Genomic instability in cancer: teetering on the limit of tolerance. Cancer Res. 2017;77(9):2179\u201385.","journal-title":"Cancer Res"},{"issue":"1","key":"3315_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/0976-9668.175049","volume":"7","author":"VA Sangle","year":"2016","unstructured":"Sangle VA, Bijjaragi S, Shah N, Kangane S, Ghule HM, Rani SA. Comparative study of frequency of micronuclei in normal, potentially malignant diseases and oral squamous cell carcinoma. J Nat Sci biology Med. 2016;7(1):33.","journal-title":"J Nat Sci biology Med"},{"key":"3315_CR53","doi-asserted-by":"publisher","first-page":"1210164","DOI":"10.3389\/fimmu.2023.1210164","volume":"14","author":"G Mestrallet","year":"2023","unstructured":"Mestrallet G, Brown M, Bozkus CC, Bhardwaj N. Immune escape and resistance to immunotherapy in mismatch repair deficient tumors. Front Immunol. 2023;14:1210164.","journal-title":"Front Immunol"},{"issue":"2","key":"3315_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02893450","volume":"12","author":"Y Hiraishi","year":"2006","unstructured":"Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res. 2006;12(2):87\u201391.","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"3315_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/mco.2020.2158","volume":"13","author":"M Kappler","year":"2020","unstructured":"Kappler M, Dauter K, Reich W, Bethmann D, Schwabe M, Rot S, Wickenhauser C, Al-Nawas B, Eckert AW. Prognostic impact of cytoplasmatic EGFR upregulation in patients with oral squamous cell carcinoma: A pilot study. Mol Clin Oncol. 2020;13(6):88.","journal-title":"Mol Clin Oncol"},{"key":"3315_CR56","doi-asserted-by":"publisher","first-page":"603160","DOI":"10.3389\/froh.2020.603160","volume":"1","author":"S Usman","year":"2021","unstructured":"Usman S, Jamal A, Teh M-T, Waseem A. Major molecular signaling pathways in oral cancer associated with therapeutic resistance. Front Oral Health. 2021;1:603160.","journal-title":"Front Oral Health"},{"issue":"1","key":"3315_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12916-022-02327-y","volume":"20","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang X, Xu Y, Li J, Zhang X, Peng Z, Hu Y, Zhao X, Dong K, Zhang B. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR\/MSI-H gastric adenocarcinoma. BMC Med. 2022;20(1):133.","journal-title":"BMC Med"},{"issue":"1","key":"3315_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s43556-024-00176-0","volume":"5","author":"S Zheng","year":"2024","unstructured":"Zheng S, He S, Liang Y, Tan Y, Liu Q, Liu T, Lu X. Understanding PI3K\/Akt\/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Mol Biomed. 2024;5(1):13.","journal-title":"Mol Biomed"},{"key":"3315_CR59","doi-asserted-by":"publisher","first-page":"113729","DOI":"10.1016\/j.bcp.2019.113729","volume":"172","author":"FE Marquard","year":"2020","unstructured":"Marquard FE, Juecker M. PI3K\/AKT\/mTOR signaling as a molecular target in head and neck cancer. Biochem Pharmacol. 2020;172:113729.","journal-title":"Biochem Pharmacol"},{"issue":"40","key":"3315_CR60","doi-asserted-by":"publisher","first-page":"68641","DOI":"10.18632\/oncotarget.19817","volume":"8","author":"C-C Yu","year":"2017","unstructured":"Yu C-C, Hung S-K, Lin H-Y, Chiou W-Y, Lee M-S, Liao H-F, Huang H-B, Ho H-C, Su Y-C. Targeting the PI3K\/AKT\/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo. Oncotarget. 2017;8(40):68641.","journal-title":"Oncotarget"},{"issue":"1","key":"3315_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12263-022-00705-y","volume":"17","author":"M Peng","year":"2022","unstructured":"Peng M, Fan S, Li J, Zhou X, Liao Q, Tang F, Liu W. Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K\/AKT and Raf\/MEK\/ERK pathways in tongue squamous cell carcinoma. Genes Nutr. 2022;17(1):3.","journal-title":"Genes Nutr"},{"issue":"9","key":"3315_CR62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"3315_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/BST20220838","volume":"51","author":"B Beernaert","year":"2023","unstructured":"Beernaert B, Parkes EE. cGAS\u2013STING signalling in cancer: striking a balance with chromosomal instability. Biochem Soc Trans. 2023;51(2):539\u201355.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"3315_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-023-00609-z","volume":"10","author":"M Chen","year":"2024","unstructured":"Chen M, Yu S, van der Sluis T, Zwager MC, Schr\u00f6der CP, van der Vegt B, van Vugt MA. cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer. NPJ Breast Cancer. 2024;10(1):1.","journal-title":"NPJ Breast Cancer"},{"key":"3315_CR65","doi-asserted-by":"crossref","unstructured":"Aloraini GS. 2025. Mitochondrial DNA release and cGAS-STING activation: Emerging insights into anti-tumor immunity. Pathology-Research Pract. 156158.","DOI":"10.1016\/j.prp.2025.156158"},{"issue":"1","key":"3315_CR66","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12903-021-01813-8","volume":"21","author":"C Zhu","year":"2021","unstructured":"Zhu C, Li J, Yao M, Fang C. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma. BMC Oral Health. 2021;21(1):506.","journal-title":"BMC Oral Health"},{"issue":"11","key":"3315_CR67","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12032-024-02539-7","volume":"41","author":"S Islam","year":"2024","unstructured":"Islam S, Islam MM, Akhand MRN, Park B-Y, Akanda MR. Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications. Med Oncol. 2024;41(11):291.","journal-title":"Med Oncol"},{"issue":"1","key":"3315_CR68","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1186\/s12967-025-06843-2","volume":"23","author":"Z Huang","year":"2025","unstructured":"Huang Z, Zhu J, Zhou YL, Shi J. The cGAS-STING pathway: a dual regulator of immune response in cancer and therapeutic implications. J Translational Med. 2025;23(1):766.","journal-title":"J Translational Med"},{"key":"3315_CR69","doi-asserted-by":"publisher","first-page":"795401","DOI":"10.3389\/fimmu.2021.795401","volume":"12","author":"Y Gan","year":"2022","unstructured":"Gan Y, Li X, Han S, Liang Q, Ma X, Rong P, Wang W, Li W. The cGAS\/STING pathway: a novel target for cancer therapy. Front Immunol. 2022;12:795401.","journal-title":"Front Immunol"},{"issue":"1","key":"3315_CR70","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-025-03555-9","volume":"44","author":"Z Li","year":"2025","unstructured":"Li Z, Zheng W, Liu Y, Cao R, Wei J, Jia H. Bridging innate and adaptive tumor immunity: cGAS\u2013STING pathway activation to potentiate immune checkpoint blockade. J Experimental Clin Cancer Res. 2025;44(1):303.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"4","key":"3315_CR71","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/gutjnl-2019-318597","volume":"69","author":"Q Hu","year":"2020","unstructured":"Hu Q, Wu J, Ren Y, Wu X, Gao L, Wang G, Gu G, Ren H, Hong Z, Slade DA. Degree of STING activation is associated with disease outcomes. Gut. 2020;69(4):792\u20134.","journal-title":"Gut"},{"issue":"1","key":"3315_CR72","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1038\/s41598-025-91700-x","volume":"15","author":"W Naeem","year":"2025","unstructured":"Naeem W, Nawab F, Sarwar MT, Khalil AT, Gaber DA, Ahmad H, Fazeel M, Alorini M, Khan IA, Irfan M. Profiling genetic mutations in the DNA damage repair genes of oral squamous cell carcinoma patients from Pakistan. Sci Rep. 2025;15(1):7896.","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"3315_CR73","doi-asserted-by":"publisher","first-page":"S1141","DOI":"10.4103\/jpbs.jpbs_185_21","volume":"13","author":"S Devadoss","year":"2021","unstructured":"Devadoss S, Raveendranath MC, Kathiresan TS, Ganesan K. Genotoxic effect of various forms of tobacco on oral buccal mucosa and nuclear changes as a biomarker. J Pharm Bioallied Sci. 2021;13(Suppl 2):S1141\u20138.","journal-title":"J Pharm Bioallied Sci"},{"issue":"9","key":"3315_CR74","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/15376516.2019.1646372","volume":"29","author":"S Khowal","year":"2019","unstructured":"Khowal S, Wajid S. Role of Smoking-Mediated molecular events in the genesis of oral cancers. Toxicol Mech Methods. 2019;29(9):665\u201385.","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"3315_CR75","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13073-025-01509-6","volume":"17","author":"RM Chabanon","year":"2025","unstructured":"Chabanon RM, Danlos F-X, Ouali K, Postel-Vinay S. Genome instability and crosstalk with the immune response. Genome Med. 2025;17(1):139.","journal-title":"Genome Med"},{"issue":"1","key":"3315_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-020-02697-y","volume":"19","author":"Z Liu","year":"2021","unstructured":"Liu Z, Zhang Y, Shi C, Zhou X, Xu K, Jiao D, Sun Z, Han X. A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma. J Translational Med. 2021;19(1):5.","journal-title":"J Translational Med"},{"key":"3315_CR77","unstructured":"Nihira NT, Kudo R, Ohta T, editors. Seminars in Cancer Biology. 2025."},{"issue":"4","key":"3315_CR78","doi-asserted-by":"publisher","first-page":"e13207","DOI":"10.1111\/cpr.13207","volume":"55","author":"W Xie","year":"2022","unstructured":"Xie W, Shen J, Wang D, Guo J, Li Q, Wen S, Dai W, Wen L, Lu H, Fang J. Dynamic changes of exhaustion features in T cells during oral carcinogenesis. Cell Prolif. 2022;55(4):e13207.","journal-title":"Cell Prolif"},{"issue":"7","key":"3315_CR79","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00262-011-1007-5","volume":"60","author":"TS de Souza Malaspina","year":"2011","unstructured":"de Souza Malaspina TS, Gasparoto TH, Costa MRSN, de Melo EF Jr, Ikoma MRV, Damante JH, Cavassani KA, Garlet GP, da Silva JS, Campanelli AP. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunol Immunother. 2011;60(7):965\u201374.","journal-title":"Cancer Immunol Immunother"},{"key":"3315_CR80","doi-asserted-by":"publisher","first-page":"693881","DOI":"10.3389\/fimmu.2021.693881","volume":"12","author":"T Wu","year":"2021","unstructured":"Wu T, Tang C, Tao R, Yong X, Jiang Q, Feng C. PD-L1-mediated immunosuppression in oral squamous cell carcinoma: relationship with macrophage infiltration and epithelial to mesenchymal transition markers. Front Immunol. 2021;12:693881.","journal-title":"Front Immunol"},{"issue":"2","key":"3315_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/ol.2024.14213","volume":"27","author":"K Todoroki","year":"2024","unstructured":"Todoroki K, Abe Y, Matsuo K, Nomura H, Kawahara A, Nakamura Y, Nakamura M, Seki N, Kusukawa J. Prognostic effect of programmed cell death ligand 1\/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma. Oncol Lett. 2024;27(2):79.","journal-title":"Oncol Lett"},{"issue":"3","key":"3315_CR82","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/cre2.590","volume":"8","author":"R Nocini","year":"2022","unstructured":"Nocini R, Vianini M, Girolami I, Calabrese L, Scarpa A, Martini M, Morbini P, Marletta S, Brunelli M, Molteni G. PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside. Clin Experimental Dent Res. 2022;8(3):690\u20138.","journal-title":"Clin Experimental Dent Res"},{"issue":"1","key":"3315_CR83","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1515\/med-2020-0041","volume":"15","author":"Y-X Cui","year":"2020","unstructured":"Cui Y-X, Su X-S. Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma. Open Med. 2020;15(1):292\u2013301.","journal-title":"Open Med"},{"issue":"1","key":"3315_CR84","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, Zeng Z, Li G, Xiong W, Yi M, Xiang B. Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer. 2024;23(1):108.","journal-title":"Mol Cancer"},{"issue":"6","key":"3315_CR85","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jaci.2013.06.010","volume":"132","author":"F Lan","year":"2013","unstructured":"Lan F, Zhang N, Zhang J, Krysko O, Zhang Q, Xian J, Derycke L, Qi Y, Li K, Liu S. Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3. J allergy Clin Immunol. 2013;132(6):1314\u201321. e1313.","journal-title":"J allergy Clin Immunol"},{"issue":"5","key":"3315_CR86","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/cdd.2011.9","volume":"18","author":"CE Pasi","year":"2011","unstructured":"Pasi CE, Dereli-\u00d6z A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G. Genomic instability in induced stem cells. Cell Death Differ. 2011;18(5):745\u201353.","journal-title":"Cell Death Differ"},{"issue":"21","key":"3315_CR87","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu B-M, Tato C, Yoshimura A, Hennighausen L, O\u2019Shea JJ. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci. 2006;103(21):8137\u201342.","journal-title":"Proc Natl Acad Sci"},{"key":"3315_CR88","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.gene.2017.06.013","volume":"627","author":"Q Chu","year":"2017","unstructured":"Chu Q, Shen D, He L, Wang H, Liu C, Zhang W. Prognostic significance of SOCS3 and its biological function in colorectal cancer. Gene. 2017;627:114\u201322.","journal-title":"Gene"},{"issue":"17","key":"3315_CR89","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-016-2234-x","volume":"73","author":"R Mahony","year":"2016","unstructured":"Mahony R, Ahmed S, Diskin C, Stevenson N. SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci. 2016;73(17):3323\u201336.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3315_CR90","first-page":"1","volume":"3","author":"T Trivedi","year":"2017","unstructured":"Trivedi T, Kobawala T, Ghosh N, Gajjar K, Goswami J. Clinical Relevance of SOCS1 and SOCS3 in Patients with Oral Squamous Cell Carcinoma. Am J Cancer Res. 2017;3(1):1\u201314.","journal-title":"Am J Cancer Res"},{"issue":"8","key":"3315_CR91","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jso.24782","volume":"116","author":"S Aggarwal","year":"2017","unstructured":"Aggarwal S, Sharma SC, Das N S. Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma. J Surg Oncol. 2017;116(8):1103\u201313.","journal-title":"J Surg Oncol"},{"key":"3315_CR92","doi-asserted-by":"crossref","unstructured":"Gasparoto TH, de Souza Malaspina TS, Benevides L, de Melo EJF Jr, Costa MRSN, Damante JH, Ikoma MRV, Garlet GP, Cavassani KA, da Silva JS. 2010. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer immunology, immunotherapy. 59(6): 819\u2013828.","DOI":"10.1007\/s00262-009-0803-7"},{"issue":"1","key":"3315_CR93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/ol_00000023","volume":"1","author":"G Moreira","year":"2010","unstructured":"Moreira G, Fulg\u00eancio LB, De Mendon\u00e7a EF, Leles CR, Batista AC, Da Silva TA. T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness. Oncol Lett. 2010;1(1):127\u201332.","journal-title":"Oncol Lett"},{"key":"3315_CR94","doi-asserted-by":"publisher","first-page":"961410","DOI":"10.3389\/fmolb.2022.961410","volume":"9","author":"J He","year":"2022","unstructured":"He J, Liu D, Liu M, Tang R, Zhang D. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors. Front Mol Biosci. 2022;9:961410.","journal-title":"Front Mol Biosci"},{"key":"3315_CR95","doi-asserted-by":"publisher","first-page":"1095419","DOI":"10.3389\/fcell.2023.1095419","volume":"11","author":"R Abou Khouzam","year":"2023","unstructured":"Abou Khouzam R, Sharda M, Rao SP, Kyerewah-Kersi SM, Zeinelabdin NA, Mahmood AS, Nawafleh H, Khan MS, Venkatesh GH, Chouaib S. Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells. Front cell Dev biology. 2023;11:1095419.","journal-title":"Front cell Dev biology"},{"issue":"5","key":"3315_CR96","doi-asserted-by":"publisher","first-page":"e18010","DOI":"10.1111\/jcmm.18010","volume":"28","author":"JE Wu","year":"2024","unstructured":"Wu JE, Li Y, Hou J. Downregulation of SLC3A2 mediates immune evasion and accelerates metastasis in oral squamous cell carcinoma. J Cell Mol Med. 2024;28(5):e18010.","journal-title":"J Cell Mol Med"},{"key":"3315_CR97","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cancers12071760","volume":"12","author":"A Cornel","year":"2020","unstructured":"Cornel A, Mimpen I, Nierkens S. MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy. Cancers. 2020a;12:1760.","journal-title":"Cancers"},{"key":"3315_CR98","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer immune evasion through loss of MHC class I antigen presentation. Front Immunol. 2021;12:636568.","journal-title":"Front Immunol"},{"issue":"1","key":"3315_CR99","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20181076","volume":"216","author":"MD Bern","year":"2019","unstructured":"Bern MD, Parikh BA, Yang L, Beckman DL, Poursine-Laurent J, Yokoyama WM. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216(1):99\u2013116.","journal-title":"J Exp Med"},{"issue":"4","key":"3315_CR100","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/JLB.4MR0620-091R","volume":"108","author":"AM Merino","year":"2020","unstructured":"Merino AM, Kim H, Miller JS, Cichocki F. Unraveling exhaustion in adaptive and conventional NK cells. J Leucocyte Biology. 2020;108(4):1361\u20138.","journal-title":"J Leucocyte Biology"},{"issue":"2","key":"3315_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imm.13464","volume":"166","author":"K Roe","year":"2022","unstructured":"Roe K. NK-cell exhaustion, B\u2010cell exhaustion and T\u2010cell exhaustion\u2014the differences and similarities. Immunology. 2022;166(2):155\u201368.","journal-title":"Immunology"},{"issue":"4","key":"3315_CR102","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.arcmed.2009.04.004","volume":"40","author":"Q Tang","year":"2009","unstructured":"Tang Q, Zhang J, Qi B, Shen C, Xie W. Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines. Arch Med Res. 2009;40(4):256\u201363.","journal-title":"Arch Med Res"},{"key":"3315_CR103","doi-asserted-by":"publisher","first-page":"844866","DOI":"10.3389\/fimmu.2022.844866","volume":"13","author":"BC Taylor","year":"2022","unstructured":"Taylor BC, Balko JM. Mechanisms of MHC-I downregulation and role in immunotherapy response. Front Immunol. 2022;13:844866.","journal-title":"Front Immunol"},{"issue":"17","key":"3315_CR104","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3390\/cancers16172997","volume":"16","author":"J Talapko","year":"2024","unstructured":"Talapko J, Eri\u0107 S, Me\u0161trovi\u0107 T, Stipeti\u0107 MM, Juzba\u0161i\u0107 M, Katalini\u0107 D, Beki\u0107 S, Mur\u0161i\u0107 D, Flam J, Beli\u0107 D. The impact of oral microbiome dysbiosis on the aetiology, pathogenesis, and development of oral cancer. Cancers. 2024;16(17):2997.","journal-title":"Cancers"},{"key":"3315_CR105","doi-asserted-by":"crossref","unstructured":"Chopra A, Shiheido-Watanabe Y, Eberhard J. 2023. Porphyromonas gingivalis: molecular mechanisms of invasion, immune evasion, and dysbiosis. In: Frontiers Media SA. p. 1289103.","DOI":"10.3389\/fcimb.2023.1289103"},{"issue":"4","key":"3315_CR106","first-page":"3045","volume":"19","author":"GRM La Rosa","year":"2020","unstructured":"La Rosa GRM, Gattuso G, Pedull\u00e0 E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett. 2020;19(4):3045\u201358.","journal-title":"Oncol Lett"},{"key":"3315_CR107","doi-asserted-by":"publisher","first-page":"100813","DOI":"10.1016\/j.neo.2022.100813","volume":"31","author":"C Michikawa","year":"2022","unstructured":"Michikawa C, Gopalakrishnan V, Harrandah AM, Karpinets TV, Garg RR, Chu RA, Park YP, Chukkapallia SS, Yadlapalli N, Erikson-Carter KC. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1). Neoplasia. 2022;31:100813.","journal-title":"Neoplasia"},{"key":"3315_CR108","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.mrgentox.2015.07.011","volume":"793","author":"A Ramakumar","year":"2015","unstructured":"Ramakumar A, Subramanian U, Prasanna PG. High-throughput sample processing and sample management; the functional evolution of classical cytogenetic assay towards automation. Mutat Research\/Genetic Toxicol Environ Mutagen. 2015;793:132\u201341.","journal-title":"Mutat Research\/Genetic Toxicol Environ Mutagen"},{"issue":"7","key":"3315_CR109","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11626-025-01068-5","volume":"61","author":"MM Ali","year":"2025","unstructured":"Ali MM, Afzal S, Javed M, Rashid I, Awan F, Ullah A, Majeed T, Darwish H, Noureldeen A, Albaqami J. Cyto-genotoxic assessment of bisphenol P through expression of DNA damage\/repair genes in MDBK cell line: MM Ali et al. Vitro Cell Dev Biology-Animal. 2025;61(7):763\u201373.","journal-title":"Vitro Cell Dev Biology-Animal"},{"issue":"1","key":"3315_CR110","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41021-016-0044-x","volume":"38","author":"M Hayashi","year":"2016","unstructured":"Hayashi M. The micronucleus test\u2014most widely used in vivo genotoxicity test. Genes Environ. 2016;38(1):18.","journal-title":"Genes Environ"},{"issue":"12","key":"3315_CR111","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/tox.24553","volume":"40","author":"MU Jamil","year":"2025","unstructured":"Jamil MU, Ali MM, Firyal S, Ijaz M, Awan F, Ullah A. Comparative cytotoxic and genotoxic assessment of methylparaben and propylparaben on Allium cepa root tips by comet and Allium cepa assays. Environ Toxicol. 2025;40(12):1417\u201326.","journal-title":"Environ Toxicol"},{"issue":"6","key":"3315_CR112","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/mutage\/ges041","volume":"27","author":"G Speit","year":"2012","unstructured":"Speit G, Linsenmeyer R, Sch\u00fctz P, Kuehner S. Insensitivity of the in vitro cytokinesis-block micronucleus assay with human lymphocytes for the detection of DNA damage present at the start of the cell culture. Mutagenesis. 2012;27(6):743\u20137.","journal-title":"Mutagenesis"},{"issue":"21","key":"3315_CR113","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1021\/acsomega.0c00149","volume":"5","author":"B Ruiz-Ruiz","year":"2020","unstructured":"Ruiz-Ruiz B, Arellano-Garc\u00eda ME, Radilla-Ch\u00e1vez P, Salas-Vargas DS, Toledano-Maga\u00f1a Y, Casillas-Figueroa F, Luna Vazquez-Gomez R, Pestryakov A, Garc\u00eda-Ramos JC, Bogdanchikova N. Cytokinesis-block micronucleus assay using human lymphocytes as a sensitive tool for cytotoxicity\/genotoxicity evaluation of AgNPs. ACS omega. 2020;5(21):12005\u201315.","journal-title":"ACS omega"},{"issue":"5","key":"3315_CR114","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1134\/S0006297916050035","volume":"81","author":"O Kisurina-Evgenieva","year":"2016","unstructured":"Kisurina-Evgenieva O, Sutiagina O, Onishchenko G. Biogenesis of micronuclei. Biochem (moscow). 2016;81(5):453\u201364.","journal-title":"Biochem (moscow)"},{"key":"3315_CR115","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ecoenv.2017.11.003","volume":"148","author":"G Gajski","year":"2018","unstructured":"Gajski G, Geri\u0107 M, Ore\u0161\u010danin V, Garaj-Vrhovac V. Cytokinesis-block micronucleus cytome assay parameters in peripheral blood lymphocytes of the general population: contribution of age, sex, seasonal variations and lifestyle factors. Ecotoxicol Environ Saf. 2018;148:561\u201370.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"11","key":"3315_CR116","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3390\/biom12111570","volume":"12","author":"BB Morris","year":"2022","unstructured":"Morris BB, Smith JP, Zhang Q, Jiang Z, Hampton OA, Churchman ML, Arnold SM, Owen DH, Gray JE, Dillon PM. Replicative instability drives cancer progression. Biomolecules. 2022;12(11):1570.","journal-title":"Biomolecules"},{"key":"3315_CR117","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2016.11.050","volume":"107","author":"M Saki","year":"2017","unstructured":"Saki M, Prakash A. DNA damage related crosstalk between the nucleus and mitochondria. Free Radic Biol Med. 2017;107:216\u201327.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3315_CR118","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cub.2020.11.037","volume":"31","author":"P Shah","year":"2021","unstructured":"Shah P, Hobson CM, Cheng S, Colville MJ, Paszek MJ, Superfine R, Lammerding J. Nuclear deformation causes DNA damage by increasing replication stress. Curr Biol. 2021;31(4):753\u201365. e756.","journal-title":"Curr Biol"},{"issue":"7392","key":"3315_CR119","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature10909","volume":"484","author":"O Hakim","year":"2012","unstructured":"Hakim O, Resch W, Yamane A, Klein I, Kieffer-Kwon K-R, Jankovic M, Oliveira T, Bothmer A, Voss TC, Ansarah-Sobrinho C. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature. 2012;484(7392):69\u201374.","journal-title":"Nature"},{"issue":"23","key":"3315_CR120","doi-asserted-by":"publisher","first-page":"16903","DOI":"10.3390\/ijms242316903","volume":"24","author":"JA Nickoloff","year":"2023","unstructured":"Nickoloff JA, Jaiswal AS, Sharma N, Williamson EA, Tran MT, Arris D, Yang M, Hromas R. Cellular responses to widespread DNA replication stress. Int J Mol Sci. 2023;24(23):16903.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3315_CR121","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/genes11040409","volume":"11","author":"S Ragu","year":"2020","unstructured":"Ragu S, Matos-Rodrigues G, Lopez BS. Replication stress, DNA damage, inflammatory cytokines and innate immune response. Genes. 2020;11(4):409.","journal-title":"Genes"},{"issue":"9","key":"3315_CR122","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrg.2017.46","volume":"18","author":"H T\u00e9cher","year":"2017","unstructured":"T\u00e9cher H, Koundrioukoff S, Nicolas A, Debatisse M. The impact of replication stress on replication dynamics and DNA damage in vertebrate cells. Nat Rev Genet. 2017;18(9):535\u201350.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"3315_CR123","first-page":"25","volume":"2","author":"A Haveri\u0107","year":"2018","unstructured":"Haveri\u0107 A, \u010cakar J, Had\u017ei\u0107 M, Haveri\u0107 S. Evaluation of cytotoxicity and genotoxicity of Micromeria pulegium (Rochel) Benth extract in human lymphocytes and Gr-M melanoma cells in vitro. Genet Appl. 2018;2(1):25\u201331.","journal-title":"Genet Appl"},{"issue":"9","key":"3315_CR124","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1080\/09553002.2021.1941378","volume":"97","author":"E Beyls","year":"2021","unstructured":"Beyls E, Baeyens A, Vral A. The cytokinesis-block micronucleus assay for cryopreserved whole blood. Int J Radiat Biol. 2021;97(9):1252\u201360.","journal-title":"Int J Radiat Biol"},{"key":"3315_CR125","doi-asserted-by":"crossref","unstructured":"Ali MM, Sahar T, Firyal S, Ijaz M, Majeed KA, Awan F, Adil M, Akbar H, Rashid MI, Ci\u011ferci \u0130H. 2022. Assessment of cytotoxic, genotoxic, and oxidative stress of dibutyl phthalate on cultured bovine peripheral lymphocytes. Oxidative Medicine and Cellular Longevity. 2022(1): 9961513.","DOI":"10.1155\/2022\/9961513"},{"issue":"5","key":"3315_CR126","doi-asserted-by":"publisher","first-page":"e0296255","DOI":"10.1371\/journal.pone.0296255","volume":"19","author":"MM Ali","year":"2024","unstructured":"Ali MM, Farhad Z, Wasim M, Raza S, Almutairi MH, Zahra K, Saleem MU, Mehmood K. Evaluation of genotoxic effect via expression of DNA damage responsive gene induced by ivermectin on MDBK cell line. PLoS ONE. 2024;19(5):e0296255.","journal-title":"PLoS ONE"},{"issue":"2","key":"3315_CR127","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1039\/C2MD20141K","volume":"4","author":"F Arjmand","year":"2013","unstructured":"Arjmand F, Muddassir M, Zaidi Y, Ray D. Design, synthesis and crystal structure determination of dinuclear copper-based potential chemotherapeutic drug entities; in vitro DNA binding, cleavage studies and an evaluation of genotoxicity by micronucleus test and comet assay. MedChemComm. 2013;4(2):394\u2013405.","journal-title":"MedChemComm"},{"issue":"4\u20135","key":"3315_CR128","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.oraloncology.2008.07.016","volume":"45","author":"JA Woolgar","year":"2009","unstructured":"Woolgar JA, Triantafyllou A. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 2009;45(4\u20135):361\u201385.","journal-title":"Oral Oncol"},{"issue":"15\u201316","key":"3315_CR129","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1101\/gad.348319.121","volume":"35","author":"O Shoshani","year":"2021","unstructured":"Shoshani O, Bakker B, De Haan L, Tijhuis AE, Wang Y, Kim DH, Maldonado M, Demarest MA, Artates J, Zhengyu O. Transient genomic instability drives tumorigenesis through accelerated clonal evolution. Genes Dev. 2021;35(15\u201316):1093\u2013108.","journal-title":"Genes Dev"},{"key":"3315_CR130","doi-asserted-by":"crossref","unstructured":"Sharma S, Upadhyay AK, Prakash A, Singodia P, Kiran SR, Shankar R. 2024. Treatment complications of head and neck cancers and rehabilitation measures: a narrative review. Cureus. 16(5).","DOI":"10.7759\/cureus.61173"},{"issue":"9","key":"3315_CR131","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/em.22240","volume":"59","author":"VS Dhillon","year":"2018","unstructured":"Dhillon VS, Yeoh E, Salisbury C, Butters J, Di Matteo A, Olver I, Fenech M. Cytokinesis block micronucleus cytome (CBMN Cyt) assay biomarkers and their association with radiation sensitivity phenotype in prostate cancer cases and DNA repair gene hOGG1 (C1245G) polymorphism. Environ Mol Mutagen. 2018;59(9):813\u201321.","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"3315_CR132","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11033-025-11329-x","volume":"53","author":"Y Huang","year":"2026","unstructured":"Huang Y, Ullah A, Ali MM. Mechanistic insights into the dynamics of plasma membrane repair in cancer. Mol Biol Rep. 2026;53(1):163.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3315_CR133","first-page":"65","volume":"3","author":"M Tijare","year":"2011","unstructured":"Tijare M, Mathur V. Genomic instability in oral cancer: An update and review. Int J Dent Clin. 2011;3(2):65\u20138.","journal-title":"Int J Dent Clin"},{"key":"3315_CR134","doi-asserted-by":"crossref","unstructured":"Cheng Y, Song Z, Chen J, Tang Z, Wang B. 2024. Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1\/PD-L1 related immunotherapy methods. Heliyon 10(4).","DOI":"10.1016\/j.heliyon.2024.e25895"},{"key":"3315_CR135","doi-asserted-by":"crossref","unstructured":"Nersesyan A, Proietti S, Knasmueller S, Bonassi S, Fenech M. 2025. High correlation between micronuclei in lymphocytes and buccal cells in humans provides further validation of their use as biomarkers of DNA damage and cancer risks in vivo. Mutagenesis. geaf006.","DOI":"10.1093\/mutage\/geaf006"},{"issue":"1","key":"3315_CR136","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1038\/s41598-019-44206-2","volume":"9","author":"SH Yoo","year":"2019","unstructured":"Yoo SH, Keam B, Ock C-Y, Kim S, Han B, Kim J-W, Lee K-W, Jeon YK, Jung KC, Chung E-J. Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients. Sci Rep. 2019;9(1):7680.","journal-title":"Sci Rep"},{"issue":"11","key":"3315_CR137","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/life12111807","volume":"12","author":"SS Venkatesiah","year":"2022","unstructured":"Venkatesiah SS, Augustine D, Mishra D, Gujjar N, Haragannavar VC, Awan KH, Patil S. Immunology of oral squamous cell carcinoma\u2014a comprehensive insight with recent concepts. Life. 2022;12(11):1807.","journal-title":"Life"},{"issue":"20","key":"3315_CR138","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1016\/j.molcel.2022.09.007","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, Goldberg EM, Chen X, Xu X, McGuire JT, Leuzzi G, Karagiannis D, Tate T, Farhangdoost N, Horth C. Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. Mol Cell. 2022;82(20):3901\u201318. e3907.","journal-title":"Mol Cell"},{"issue":"24","key":"3315_CR139","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.3390\/jcm11247259","volume":"11","author":"K Kirtane","year":"2022","unstructured":"Kirtane K, Fuentes-Bayne SJM, Patel H, Mardiros SP, Xu A, Ng H, Go EW, Wong WY, Sunwoo DJ JB. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. J Clin Med. 2022;11(24):7259.","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"3315_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cccn.2004.04.010","volume":"347","author":"SW Maluf","year":"2004","unstructured":"Maluf SW. Monitoring DNA damage following radiation exposure using cytokinesis\u2013block micronucleus method and alkaline single-cell gel electrophoresis. Clin Chim Acta. 2004;347(1\u20132):15\u201324.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3315_CR141","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4103\/jomfp.jomfp_134_23","volume":"27","author":"M Janardhanan","year":"2023","unstructured":"Janardhanan M, Smitha N, Rajalakshmi G, George A, Koyakutty M, Iyer S. Tumour Microenvironment as a Potential Immune Therapeutic Target for Tongue Cancer Management. J Oral Maxillofacial Pathol. 2023;27(2):382\u20139.","journal-title":"J Oral Maxillofacial Pathol"},{"issue":"7","key":"3315_CR142","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cancers12071760","volume":"12","author":"AM Cornel","year":"2020","unstructured":"Cornel AM, Mimpen IL, Nierkens S. MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy. Cancers. 2020b;12(7):1760.","journal-title":"Cancers"},{"issue":"7","key":"3315_CR143","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/bjc.2014.416","volume":"111","author":"X Wu","year":"2014","unstructured":"Wu X, Zhang H, Xing Q, Cui J, Li J, Li Y, Tan Y, Wang S. PD-1\u2009+\u2009CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients. Br J Cancer. 2014;111(7):1391\u20139.","journal-title":"Br J Cancer"},{"issue":"5","key":"3315_CR144","first-page":"2363","volume":"12","author":"Z Xue","year":"2022","unstructured":"Xue Z, Zheng S, Linghu D, Liu B, Yang Y, Chen M-K, Huang H, Song J, Li H, Wang J. PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation. Am J Cancer Res. 2022;12(5):2363.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"3315_CR145","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/bjc.2014.47","volume":"110","author":"G Ma","year":"2014","unstructured":"Ma G, Miao Q, Liu Y, Gao H, Lian J, Wang Y, Zeng X, Luo T, Ma L, Shen Z. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment. Br J Cancer. 2014;110(6):1552\u201360.","journal-title":"Br J Cancer"},{"key":"3315_CR146","doi-asserted-by":"crossref","unstructured":"Moghadam MS, Azimian H, Afshari JT, Toossi MTB, Farkhad NK, Aghaee-Bakhtiari SH. 2023. Chromosomal instability in various generations of human mesenchymal stem cells following the therapeutic radiation. Stem Cells International. 2023: 9991656.","DOI":"10.21203\/rs.3.rs-2253587\/v1"},{"issue":"1","key":"3315_CR147","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41467-022-29122-w","volume":"13","author":"PH Nguyen","year":"2022","unstructured":"Nguyen PH, Wasser M, Tan CT, Lim CJ, Lai HL, Seow JJW, DasGupta R, Phua CZ, Ma S, Yang J. Trajectory of immune evasion and cancer progression in hepatocellular carcinoma. Nat Commun. 2022;13(1):1441.","journal-title":"Nat Commun"},{"key":"3315_CR148","doi-asserted-by":"crossref","unstructured":"Ameya K, PP ASU, Sekar D. 2025. OIP5-AS1 expression profiles in different stages of oral squamous cell carcinoma. Arch Oral Biol 106403.","DOI":"10.1016\/j.archoralbio.2025.106403"},{"key":"3315_CR149","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.placenta.2024.09.018","volume":"158","author":"SC Selvakumar","year":"2024","unstructured":"Selvakumar SC, Preethi KA, Ross K, Sekar D. The emerging role of microRNA-based therapeutics in the treatment of preeclampsia. Placenta. 2024;158:38\u201347.","journal-title":"Placenta"},{"key":"3315_CR150","doi-asserted-by":"crossref","unstructured":"Varshan M, Selvakumar SC, Preethi K, Murthykumar K, Sekar D. MicroRNA-34a-3p and its target tumor necrosis factor-\u03b1 in the regulation of South Indian oral squamous cell carcinoma population. Minerva Dental and Oral Science; 2023.","DOI":"10.23736\/S2724-6329.23.04835-0"},{"issue":"7","key":"3315_CR151","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.21037\/tlcr-2025-117","volume":"14","author":"A Kaneko","year":"2025","unstructured":"Kaneko A, Kobayashi N, Kubo S, Nagaoka S, Muraoka S, Fukuda N, Somekawa K, Matsumoto H, Katakura S, Teranishi S. MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Translational Lung Cancer Res. 2025;14(7):2522.","journal-title":"Translational Lung Cancer Res"},{"issue":"8","key":"3315_CR152","first-page":"4107","volume":"17","author":"S Anil","year":"2016","unstructured":"Anil S, PB G, Basheer AB, Alogaibi BGV, Chalisserry YA, Javed EP, Dalati F, Vellappally M, Hashem S MI. Association of poly (ADP-Ribose) polymerase 1 variants with oral squamous cell carcinoma susceptibility in a South Indian population. Asian Pac J Cancer Prev. 2016;17(8):4107\u201311.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3315_CR153","doi-asserted-by":"publisher","first-page":"678464","DOI":"10.3389\/fcell.2021.678464","volume":"9","author":"J Guo","year":"2021","unstructured":"Guo J, Liu X, Zeng Y, Liang T, Tang K, Guo J, Zheng W. Comprehensive Analysis of the Effects of Genetic Ancestry and Genetic Characteristics on the Clinical Evolution of Oral Squamous Cell Carcinoma. Front Cell Dev Biology. 2021;9:678464.","journal-title":"Front Cell Dev Biology"},{"key":"3315_CR154","doi-asserted-by":"publisher","first-page":"1452909","DOI":"10.3389\/fonc.2024.1452909","volume":"14","author":"D Lenoci","year":"2024","unstructured":"Lenoci D, Moresco E, Cavalieri S, Bergamini C, Torchia E, Botta L, Canevari S, Trama A, Licitra L, De Cecco L. Oral cancer in young adults: incidence, risk factors, prognosis, and molecular biomarkers. Front Oncol. 2024;14:1452909.","journal-title":"Front Oncol"},{"key":"3315_CR155","doi-asserted-by":"publisher","first-page":"107079","DOI":"10.1016\/j.oraloncology.2024.107079","volume":"159","author":"N Ichimura","year":"2024","unstructured":"Ichimura N, Urata Y, Kobayashi T, Ebata R, Matsumoto H, Hibi H. Mutational landscape of Japanese patients with oral squamous cell carcinoma from comprehensive genomic profiling tests. Oral Oncol. 2024;159:107079.","journal-title":"Oral Oncol"},{"issue":"8","key":"3315_CR156","first-page":"1824","volume":"7","author":"C Seethalakshmi","year":"2013","unstructured":"Seethalakshmi C. Early detection of oral squamous cell carcinoma (OSCC)\u2013Role of genetics: A literature review. J Clin Diagn research: JCDR. 2013;7(8):1824.","journal-title":"J Clin Diagn research: JCDR"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03315-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03315-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03315-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:02:23Z","timestamp":1785751343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03315-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":156,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03315-5","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Article has been corrected","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}